Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Not on Peppol Peppol
Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.
Financials
Financial year 2025
Dauwe Pharma Consultancy from Kontich, company number BE0786571119, closed financial year 2025 with a result of € 79 after tax. For that financial year Dauwe Pharma Consultancy recorded a gross margin of € -4,144 and equity of € 169,357. Compared with financial year 2024, the result moved from € 499 to € 79. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 9, 2026.
€ 169,357
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 79
▼ 84% vs 2024
Profit after tax over the fiscal year.
€ 81,765
▼ 49% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 167,357.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 79
▼ 94% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 146
▼ € 70,665 vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € -13,782 | € 250,839 | € -3,915 | € -4,144 | ▼ € 229 |
| Profit after taxes | € -13,811 | € 180,590 | € 499 | € 79 | ▼ 84% |
| Equity | € -11,811 | € 168,779 | € 169,278 | € 169,357 | |
| Total debts | € 15,968 | € 71,448 | € 72,173 | € 225 | ▼ € 71,948 |
| Cash | € 2,071 | € 165,585 | € 159,952 | € 81,765 | ▼ 49% |
| Retained profit | € -13,811 | € 166,779 | € 167,278 | € 167,357 | |
| Balance sheet total | € 4,157 | € 240,227 | € 241,451 | € 169,582 | ▼ 30% |
Key figures of Dauwe Pharma Consultancy, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Dauwe Pharma Consultancy?
What happened at Dauwe Pharma Consultancy in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 79 (▼ 84% vs 2024). Source: NBB ↗
- New establishment in Kontich. KBO
- Dominic Dauwe became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 13,811 loss in 2022 to € 79 profit in 2025.
Paid € 70,832 in corporate taxes since 2022.
Best year ever: 2023, with € 180,590 profit.
A new publication or filing at Dauwe Pharma Consultancy? We notify you, reason included.
Follow Dauwe Pharma ConsultancyDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind Dauwe Pharma Consultancy is Dominic Dauwe.
Directors
According to the 2025 annual accounts
Dominic Dauwe
Director
since 2022
Establishments
Establishment units
Physical locations of this company
Eertbrugge 7
2550 Kontich
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0786.571.119
- VAT number
- BE 0786.571.119
- Registered office
- Eertbrugge 7, 2550 Kontich
- Names & denominations
- Dauwe Pharma Consultancy
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 25 May 2022
- Peppol
- Not registered
- Activities · NACE
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering